sábado, 30 de mayo de 2026
Editorial p2141 A new era in neurology The Lancet + +... + +
Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer's disease (HEAD): a multicentre, prospective, cross-sectional, within-participant study
Guilherme Povala, PhDa,* ∙ Bruna Bellaver, PhDa,* ∙ Firoza Z Lussier, MSa ∙ Livia Amaral, MSa ∙ Guilherme Bauer-Negrini, PhDa ∙ Pamela C L Ferreira, PhDa ∙ et al.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00417-4/fulltext?dgcid=hubspot_email_infocusalerts-neurology_feature_lancetneuro26&utm_campaign=infocusalerts-neurology&utm_medium=email&_hsenc=p2ANqtz-8ujTQJDAYhslHYBGpDUpx_0K9Os9kmp4PeAcWF_2cuB18ftCv178Pqz1vfY_YQeOAe2ZXPwgzy1Rc4OhQ7sVseVHNJ4g&_hsmi=421331774&utm_content=420563000&utm_source=hs_email
Editorial
p2141
A new era in neurology
The Lancet
https://www.thelancet.com/journals/lancet/issue/vol407no10544/PIIS0140-6736(26)X2019-0
Alzheimer's disease
Alberto Serrano-Pozo, MD PhDa,b,c Send email to aserrano1@mgh.harvard.edu ∙ Prof Valentina Escott-Price, PhDd,e ∙ Prof Lea T Grinberg, MD PhDf ∙ Tharick Pascoal, MD PhDg,h ∙ Marc Suárez-Calvet, MD PhDi,j ∙ Prof Bruno Dubois, MDk,l ∙ et al.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00198-4/abstract?utm_campaign=infocusalerts-neurology&utm_medium=email&dgcid=hubspot_email_infocusalerts-neurology_feature_lancetneuro26&_hsenc=p2ANqtz-9k3jQnYevg0uj5SxI80gLmEfvlwjqHWAJYtswfqGMfseP5cQL0HW6IdEf9fVGrTyGlMLAlvimkY2sVkLdOyypZB_YllA&_hsmi=421331774&utm_content=420563000&utm_source=hs_email
Integrating peripheral immune control and brain health in the multiple sclerosis continuum
Eleonora Cocco
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00829-9/abstract?utm_campaign=infocusalerts-neurology&utm_medium=email&dgcid=hubspot_email_infocusalerts-neurology_feature_lancetneuro26&_hsenc=p2ANqtz-8GWqCa3ivRgyNXD2SXoIwEPV0MBEjA9PEJArb61cwurvs-NTfuKQ-qNhY8dWMK4FM6GUMrdaRKd4NkFa8zVm2ojHoviQ&_hsmi=421331774&utm_content=420563000&utm_source=hs_email
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario